Interestingly, TFEB activation has been shown to reduce the accumulation of the pathogenic protein in a cellular model of Huntington's disease (HD) [28] and a mouse model of Parkinson's disease (PD) [32], which was achieved by gene transfer through viral vectors. Here, TFEB is linked to Parkinson disease.